Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3283252 | 0.77 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL10824160 | 0.74 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL4413508 | 0.74 | ALDH1A1 (0.30) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL5102949 | 0.72 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL28382592 | 0.71 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL27506904 | 0.68 | NPSR1 (0.35) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL611061 | 0.68 | ALDH1A1 (0.35) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL610462 | 0.68 | NPSR1 (0.35) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL2285727 | 0.67 | ALDH1A1 (0.41) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL29252564 | 0.67 | DRD2 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1711458-B1 | METHOD FOR PRODUCING GUANIDINIUM SALTS | MERCK PATENT GMBH (DE) | 2013-05-29 | — | — | EP | disclosed |
| US-7709656-B2 | Ionic liquids containing guanidinium cations | MERCK PATENT GMBH (DE) | 2010-05-04 | — | — | US | disclosed |
| US-7439395-B2 | Process for the preparation of guanidinium salts | MERCK PATENT GMBH (DE) | 2008-10-21 | — | — | US | disclosed |
| US-20070265453-A1 | Ionic Liquids Containing Guanidinium Cations | MERCK PATENT GMBH (DE) | 2007-11-15 | — | — | US | disclosed |
| US-20070135645-A1 | Process for the preparation of guanidinium salts | MERCK PATENT GMBH (DE) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135645-A1 | Process for the preparation of guanidinium salts | GMPS, AGPS, PFAS | TRPV4 3582/4885 |
| US-20070265453-A1 | Ionic Liquids Containing Guanidinium Cations | GMPS, GUCY1A2, GUCY1B2 | TRPV4 1881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.